The impact of therapeutic delay time on acute scintigraphic lesion and ultimate scar formation in children with first febrile UTI

Mi-Mi Oh, Jin Wook Kim, Min Gu Park, Je-Jong Kim, Kee Hwan Yoo, Du Geon Moon

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

We assessed the role of therapeutic delay time (TDT) in acute renal cortical scintigraphic lesion (ASL) and ultimate scar formation (USF) in children with first febrile UTI and whether it is affected by the presence of vesico-ureteral reflux (VUR). 230 children, 90 girls and 140 boys with first febrile UTI were included. Radiologic (USG, DMSA, and VCUG), clinical (age, gender, peak fever, therapeutic delay time) and laboratory (CBC with differential count, ANC (absolute neutrophil count), BUN, Creatinine, urine analysis, gram stain, culture, CRP and ESR) variables were analysed. DMSA was performed within 5 days and after six months. VCUG was performed after acute phase of UTI. The differences in TDT according to the presence of ASL, USF and VUR were assessed. And the correlation between ASL or USF with the duration of TDT was assessed. Of 230 patients enrolled, 142 patients had refluxing UTI and 88 patients had non-refluxing UTI. TDT was the risk factor associated with ASL and USF along with presence of VUR. TDT was longer in ASL positive group compared with the ASL negative group. Also USF group showed longer TDTcompared with those without USF in both refluxing UTI and non refluxing UTI. The TDT was significantly shorter in USF group with the presence of VUR. Positive linear association was noted between prevalence of ASL and USF and duration of TDT. In conclusion, the impact of UTI on formation of USF may be enhanced by the presence of VUR with shorter duration of TDT.

Original languageEnglish
Pages (from-to)565-570
Number of pages6
JournalEuropean Journal of Pediatrics
Volume171
Issue number3
DOIs
Publication statusPublished - 2012 Mar 1

Fingerprint

Cicatrix
Fever
Vesico-Ureteral Reflux
Succimer
Therapeutics
Blood Urea Nitrogen
Creatinine
Neutrophils
Urine
Kidney

Keywords

  • DMSA
  • Febrile UTI
  • Therapeutic delay time
  • VUR

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

The impact of therapeutic delay time on acute scintigraphic lesion and ultimate scar formation in children with first febrile UTI. / Oh, Mi-Mi; Kim, Jin Wook; Park, Min Gu; Kim, Je-Jong; Yoo, Kee Hwan; Moon, Du Geon.

In: European Journal of Pediatrics, Vol. 171, No. 3, 01.03.2012, p. 565-570.

Research output: Contribution to journalArticle

@article{68a83da6ecc843858eb03f4a0ce6ed57,
title = "The impact of therapeutic delay time on acute scintigraphic lesion and ultimate scar formation in children with first febrile UTI",
abstract = "We assessed the role of therapeutic delay time (TDT) in acute renal cortical scintigraphic lesion (ASL) and ultimate scar formation (USF) in children with first febrile UTI and whether it is affected by the presence of vesico-ureteral reflux (VUR). 230 children, 90 girls and 140 boys with first febrile UTI were included. Radiologic (USG, DMSA, and VCUG), clinical (age, gender, peak fever, therapeutic delay time) and laboratory (CBC with differential count, ANC (absolute neutrophil count), BUN, Creatinine, urine analysis, gram stain, culture, CRP and ESR) variables were analysed. DMSA was performed within 5 days and after six months. VCUG was performed after acute phase of UTI. The differences in TDT according to the presence of ASL, USF and VUR were assessed. And the correlation between ASL or USF with the duration of TDT was assessed. Of 230 patients enrolled, 142 patients had refluxing UTI and 88 patients had non-refluxing UTI. TDT was the risk factor associated with ASL and USF along with presence of VUR. TDT was longer in ASL positive group compared with the ASL negative group. Also USF group showed longer TDTcompared with those without USF in both refluxing UTI and non refluxing UTI. The TDT was significantly shorter in USF group with the presence of VUR. Positive linear association was noted between prevalence of ASL and USF and duration of TDT. In conclusion, the impact of UTI on formation of USF may be enhanced by the presence of VUR with shorter duration of TDT.",
keywords = "DMSA, Febrile UTI, Therapeutic delay time, VUR",
author = "Mi-Mi Oh and Kim, {Jin Wook} and Park, {Min Gu} and Je-Jong Kim and Yoo, {Kee Hwan} and Moon, {Du Geon}",
year = "2012",
month = "3",
day = "1",
doi = "10.1007/s00431-011-1614-3",
language = "English",
volume = "171",
pages = "565--570",
journal = "European Journal of Pediatrics",
issn = "0340-6199",
publisher = "Springer Verlag",
number = "3",

}

TY - JOUR

T1 - The impact of therapeutic delay time on acute scintigraphic lesion and ultimate scar formation in children with first febrile UTI

AU - Oh, Mi-Mi

AU - Kim, Jin Wook

AU - Park, Min Gu

AU - Kim, Je-Jong

AU - Yoo, Kee Hwan

AU - Moon, Du Geon

PY - 2012/3/1

Y1 - 2012/3/1

N2 - We assessed the role of therapeutic delay time (TDT) in acute renal cortical scintigraphic lesion (ASL) and ultimate scar formation (USF) in children with first febrile UTI and whether it is affected by the presence of vesico-ureteral reflux (VUR). 230 children, 90 girls and 140 boys with first febrile UTI were included. Radiologic (USG, DMSA, and VCUG), clinical (age, gender, peak fever, therapeutic delay time) and laboratory (CBC with differential count, ANC (absolute neutrophil count), BUN, Creatinine, urine analysis, gram stain, culture, CRP and ESR) variables were analysed. DMSA was performed within 5 days and after six months. VCUG was performed after acute phase of UTI. The differences in TDT according to the presence of ASL, USF and VUR were assessed. And the correlation between ASL or USF with the duration of TDT was assessed. Of 230 patients enrolled, 142 patients had refluxing UTI and 88 patients had non-refluxing UTI. TDT was the risk factor associated with ASL and USF along with presence of VUR. TDT was longer in ASL positive group compared with the ASL negative group. Also USF group showed longer TDTcompared with those without USF in both refluxing UTI and non refluxing UTI. The TDT was significantly shorter in USF group with the presence of VUR. Positive linear association was noted between prevalence of ASL and USF and duration of TDT. In conclusion, the impact of UTI on formation of USF may be enhanced by the presence of VUR with shorter duration of TDT.

AB - We assessed the role of therapeutic delay time (TDT) in acute renal cortical scintigraphic lesion (ASL) and ultimate scar formation (USF) in children with first febrile UTI and whether it is affected by the presence of vesico-ureteral reflux (VUR). 230 children, 90 girls and 140 boys with first febrile UTI were included. Radiologic (USG, DMSA, and VCUG), clinical (age, gender, peak fever, therapeutic delay time) and laboratory (CBC with differential count, ANC (absolute neutrophil count), BUN, Creatinine, urine analysis, gram stain, culture, CRP and ESR) variables were analysed. DMSA was performed within 5 days and after six months. VCUG was performed after acute phase of UTI. The differences in TDT according to the presence of ASL, USF and VUR were assessed. And the correlation between ASL or USF with the duration of TDT was assessed. Of 230 patients enrolled, 142 patients had refluxing UTI and 88 patients had non-refluxing UTI. TDT was the risk factor associated with ASL and USF along with presence of VUR. TDT was longer in ASL positive group compared with the ASL negative group. Also USF group showed longer TDTcompared with those without USF in both refluxing UTI and non refluxing UTI. The TDT was significantly shorter in USF group with the presence of VUR. Positive linear association was noted between prevalence of ASL and USF and duration of TDT. In conclusion, the impact of UTI on formation of USF may be enhanced by the presence of VUR with shorter duration of TDT.

KW - DMSA

KW - Febrile UTI

KW - Therapeutic delay time

KW - VUR

UR - http://www.scopus.com/inward/record.url?scp=84860299971&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860299971&partnerID=8YFLogxK

U2 - 10.1007/s00431-011-1614-3

DO - 10.1007/s00431-011-1614-3

M3 - Article

VL - 171

SP - 565

EP - 570

JO - European Journal of Pediatrics

JF - European Journal of Pediatrics

SN - 0340-6199

IS - 3

ER -